21268 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Analgesic compositions
#902ANTIBODY AND PROTEIN FORMULATIONS
#903Methods for the preparation of injectable depot compositions
#904METHOD OF TRANSPORTING AN AGENT ACROSS BLOOD-BRAIN, BLOOD-COCHLEAR OR BLOOD-CEREBROSPINAL FLUID BARRIER
#905High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
#906MODIFIED RELEASE COMPOSITION COMPRISING A CANNABINOID
#907Liposome formulation of fluticasone furoate and method of preparation
#908HIGHLY CONCENTRATED PHARMACEUTICAL FORMULATIONS
#909COMPOSITION COMPRISING TETRACYCLIC COMPOUND
#910Compositions and Methods for Treating Pain with Wogonin
#911Soluble metallogels including antimicrobial silver metallogels
#912Transdermal compositions of ibuprofen and methods of use thereof
#913BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#914Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP)
#915Composition(s) for Topically Treating Pain
#916PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1-AGONIST AND METHIONINE
#917DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
#918Sublingual formulation of riluzole
#919Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC)
#920Pharmaceutical composition including sodium alkyl sulfate
#921METHODS AND COMPOSITIONS FOR TREATING CANCER
#922Density flow meter for pharmaceutical formulation dosing
#923COMPOSITIONS FOR THE DELIVERY OF tRNA AS NANOPARTICLES AND METHODS OF USE THEREWITH
#924TOPICAL COMPOSITIONS
#925Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
#926Anhydrous sodium thiosulfate and formulations thereof
#927COMPOSITIONS FOR TREATING OBESITY
#928Composition for treating onychomycosis
#929TOPICAL CANNABINOID COMPOSITIONS, DELIVERY SYSTEMS, AND USES FOR PAIN RELIEF
#930LIQUID FORMULATIONS OF BENDAMUSTINE
#931Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use
#932Transfusion preparation
#933Method of synthesis of an ionizable cationic lipid
#934Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compound
#935ANTI-CD3 ANTIBODY FORMULATIONS
#936DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
#937RETINAL PIGMENT EPITHELIUM CELL COMPOSITIONS
#938Pharmaceutical formulations of FcRn inhibitors suitable for subcutaneous administration
#939Anti-CD40 antibody formulation delivery device
#940Formulation comprising a gemcitabine-prodrug
#941Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for Same
#942NOVEL RNAi MOLECULE DELIVERY PLATFORM BASED ON SINGLE-siRNA AND shRNA NANOCAPSULES
#943Nano coordination polymer and preparation method and application thereof
#944PEPTIDE COMPOSITIONS AND RELATED METHODS
#945Polymeric hGH prodrugs
#946Targeted intracellular delivery of antiviral agents
#947TOPICAL FORMULATION
#948Liquid composition containing pradofloxacin
#949Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
#950Water soluble formulation
#951FORMULATIONS OF BENDAMUSTINE
#952Stable formulations for parenteral injection of small molecule drugs
#953HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF
#954TREATMENT COMPOSITIONS PROVIDING AN ANTIMICROBIAL BENEFIT
#955Topical anti-inflammatory compositions
#956PEPTIDE COMPOSITIONS AND RELATED METHODS
#957POLYMER FILMS WITH ANTIMICROBIAL AGENTS
#958TREATMENT OF PAIN WITH TOPICAL DICLOFENAC
#959Production of Biosimilar Ustekinumab In CHO Cells
#960Wound dressing
#961Pharmaceutical composition for sustained release delivery of buprenorphine
#962Epinephrine spray formulations
#963Subcutaneous formulations of anti-CD38 antibodies and their uses
#964Transdermal Cannabinoid Patch
#965FILM FORMULATION COMPRISING VARDENAFIL, METHOD FOR ITS PREPARATION, AND USE THEREOF
#966LONG CHAIN FATTY ACID FORMULATIONS AND THEIR USE IN INHIBITING SALMONELLA INFECTION
#967METHOD FOR TOPICAL SOLVENT-FREE AROMATIC DRUG DELIVERY SYSTEM
#968HYDROPHOBIC ARENESULFONATE SALTS
#969IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE
#970Antimicrobial composition
#971Compounds that modulate intracellular calcium
#972Biocompatible hydrogel treatments for retinal detachment
#973PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
#974Scarring reducing wound treatment
#975TEAT DIP WITH RESIDUAL EFFICACY
#976Hydrocortisone acetate suppository formulation for treatment of disease
#977MULTICOMPONENT DEGRADABLE CATIONIC POLYMERS
#978Iniparib formulations and uses thereof
#979Rinse-off compositions and uses thereof for delivery of active agents
#980FORMULATIONS OF BENDAMUSTINE
#981Edible Film Comprising Adjacent Conjoined Strips
#982Compositions and kits useful for treatment of respiratory illness
#983Combination Therapy for Cancer Treatment
#984Non-Enzymatic Debriding Agent and Method of Use Thereof
#985TOPICAL COMPOSITIONS
#986Stabilization of epinephrine formulations
#987Stabilized pharmaceutical composition containing pemetrexed or pharmaceutically acceptable salt thereof
#988Compounded compositions and methods for treating pain
#989Treatment of schizophrenia using beta-caryophyllene and CB2 receptor agonists
#990Stabilised Solid Compositions of Factor VII Polypeptides
#991Sincalide Formulations
#992Potassium enriched topical formulations for pain relief and sleep aid
#993Methods of inhibiting pathological angiogenesis
#994Delayed release pharmaceutical composition of pantoprazole and process for formulation thereof
#995VOLATILE ANESTHETIC COMPOSITIONS COMPRISING EXTRACTIVE SOLVENTS FOR REGIONAL ANESTHESIA AND/OR PAIN RELIEF
#996Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#997Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#998Dermal compositions
#999DICLOFENAC TOPICAL FORMULATION
#1000Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide
#1001Subcutaneous formulations of anti-CD38 antibodies and their uses
#1002Systems, compositions and methods for treating diabetes
#1003TOPICAL CORTICOSTEROID COMPOSITIONS
#1004Non-lethal defensive fluid composition and pressurized delivery system
#1005FOAMABLE VEHICLES AND PHARMACEUTICAL COMPOSITIONS COMPRISING APROTIC POLAR SOLVENTS AND USES THEREOF
#1006Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents
#1007TOPICAL COMPOSITIONS AND METHODS FOR TREATMENT
#1008Stable aqueous injectable solution of epinephrine
#1009Oral care compositions
#1010Epinephrine formulations
#1011Stable virus-containing composition
#1012Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#1013Melatonin for Preventing and Treating Radiation Cystitis
#1014Dispersion of formononetin solid lipid nanoparticles and process for its preparation
#1015Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action
#1016FULVESTRANT FORMULATIONS
#1017Pharmaceutical composition
#1018Stable virus-containing composition
#1019Use of inhibitors of Bruton's tyrosine kinase (Btk)
#1020INJECTABLE FORMULATION
#1021COMPOSITIONS AND METHODS FOR TREATING NERVE AGENT EXPOSURE
#1022Drug formulations
#1023Stable pharmaceutical formulations of pemetrexed
#1024RAPID ACTION INSULIN FORMULATIONS AND PHARMACEUTICAL DELIVERY SYSTEMS
#1025Compounded compositions and methods for treating pain
#1026Pharmaceutical formulation containing gelling agent
#1027COMPOSITIONS WITH PERMEATION ENHANCERS FOR DRUG DELIVERY
#1028PHARMACEUTICAL COMPOSITION
#1029Pharmaceutical compositions for delivery of peptide
#1030ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE
#1031HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF
#1032Viscosity-reducing compounds for protein formulations
#1033Compositions and methods of use of cis-4-[2-{[3S,4R)-3-fluorooxan-4-yl]amino}8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide
#1034Compositions of a polyorthoester and an aprotic solvent
#1035METHODS AND FORMULATIONS FOR TREATING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
#1036CLOSTRIDIAL TOXIN - HYALURONIC ACID COMPOSITIONS
#1037ExPEC glycoconjugate vaccine formulations
#1038COSMETIC AND PHARMACEUTICAL FOAM
#1039AQUEOUS FORMULATION AND IN-SYRINGE AQUEOUS FORMULATION, AND ANTIBODY PROTEIN DEAGGREGATION AGENT AND ANTIBODY PROTEIN DEAGGREGATION METHOD
#1040LYOPHILIZED PHARMACEUTICAL COMPOSITIONS
#1041Lipids for therapeutic agent delivery formulations
#1042Tecoma plant based compositions for treating skin lesions
#1043DEVICE AND METHOD TO TREAT OR PREVENT JOINT DEGENERATION
#1044COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL
#1045STABLE LIQUID FORMULATIONS OF MELPHALAN
#1046High concentration antibody-containing liquid formulation
#1047Factor VIII formulations
#1048Ice pop medicament delivery system and method
#1049Topical supplement composition and method of use
#1050Reaction platform and method for making pollen based materials and uses thereof
#1051TOPICAL COMPOSITIONS
#1052PHARMACEUTICAL FORMULATION CONTAINING TADALAFIL
#1053High surface-area lyophilized compositions comprising arsenic for oral administration in patients
#1054PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS
#1055Suspension formulation comprising an insulinotropic peptide
#1056Urogenital medical device formulation based on suitable biochemical compositions for the stabilization of the acidity and the redox state of the vaginal fluid
#1057Stabilised Compositions of Factor VII Polypeptides
#1058SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS
#1059DOPA decarboxylase inhibitor compositions
#1060CHEMICALLY STABLE COMPOSITIONS OF A PHARMACEUTICAL ACTIVE AGENT IN A MULTI-CHAMBERED DELIVERY SYSTEM FOR MUCOSAL DELIVERY
#1061Preparation containing tetracyclic compound at high dose
#1062COMPOSITIONS FOR RETARDING THE DECOMPOSITION OF MELATONIN IN SOLUTION
#1063Liquid composition containing pradofloxacin
#1064Sincalide Formulations
#1065ANTIMICROBIAL COMPOSITIONS AND METHODS
#1066CONJUGATES COMPRISING AN GLP-1/GLUCAGON/GIP TRIPLE RECEPTOR AGONIST, A LINKER AND HYALURONIC ACID
#1067Analgesic compositions
#1068Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
#1069Liquid pharmaceutical composition
#1070THIOL-MICHAEL ADDITION HYDROGEL-BASED BRACHYTHERAPY SYSTEM AND METHODS COMPRISING THE SAME
#1071Anhydrous sodium thiosulfate and formulations thereof
#1072DRUG COMBINATIONS
#1073Transplantation medium
#1074DIMETHYL SULFOXIDE (DMSO) AND HYDROCORTISONE COMPOSITIONS AND METHODS OF USE
#1075Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
#1076Solid Oral Pharmaceutical Compositions for Isoxazoline Compounds
#1077Ionizable cationic lipid for RNA delivery
#1078Stable 5-methyltetrahydrofolate formulations to moderate methylenetetrahydrofolate reductase associated polymorphisms
#1079Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition
#1080FORMULATIONS
#1081Injection composition containing acetaminophen
#1082STABLE LIPOSOMES FOR DRUG DELIVERY
#1083ADMINISTRATION REGIMEN FOR A PHARMACEUTICAL PATCH COMPRISING LIDOCAINE AND DICLOFENAC
#1084Highly concentrated pharmaceutical formulations
#1085Use of the FL118 core chemical structure platform to generate FL118 derivatives for treatment of human disease
#1086Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
#1087IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE
#1088TOPICAL ANTI-INFLAMMATORY COMPOSITIONS
#1089Use of inhibitors of bruton's tyrosine kinase (BTK)
#1090METHOD OF TREATING CANCER, PARASITE, MICROBIAL OR FUNGAL DISEASE
#1091FROZEN THERAPEUTIC DOSE AND PACKAGE
#1092Topical antimicrobial formulations containing monovalent copper ions and systems for generating monovalent copper ions
#1093Compositions and methods for degenerative disc regeneration
#1094Sterile formulation comprising a stable phosphorothioate oligonucleotide
#1095Formulations of bendamustine
#1096Drug-containing patch
#1097Mechanochemical activated dry amorphisation by milling equilibrium between ap mesoporous silica
#1098MICRONEEDLE DEVICE
#1099Aqueous formulation comprising paracetamol and ibuprofen
#1100Method of treating fibrosis
#1101PHARMACEUTICAL COMPOSITION
#1102Stabilised Solid Compositions of Factor VII Polypeptides
#1103Method for alleviating ultraviolet damage with ethyl acetate-extracted product of
#1104COMPOSITIONS FOR BIOLOGICAL SYSTEMS AND METHODS FOR PREPARING AND USING THE SAME
#1105Composition and method for proton pump inhibitor suspension
#1106BENZENESULFONAMIDE DERIVATIVES AND METHOD FOR TREATING CANCER
#1107Viscosity reduction of highly concentrated protein formulations
#1108Oral formulations and lipophilic salts of methylnaltrexone
#1109Combination of antibody-drug conjugate and immune checkpoint inhibitor
#1110Pharmaceutical hydrocortisone solution for an injection device
#1111Body Cavity Foams
#1112Complexes of Celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
#111317-hydroxyprogesterone ester-containing oral compositions and related methods
#1114Materials and methods for improving gastrointestinal function
#1115SEQUENTIAL CLICK REACTIONS FOR THE SYNTHESIS AND FUNCTIONALIZATION OF HYDROGEL MICROSPHERES AND SUBSTRATES
#1116Methods of Treating Multiple Myeloma
#1117PHARMACEUTICAL LIQUID COMPOSITION OF BOTULINUM TOXIN WITH IMPROVED STABILITY
#1118Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
#1119DERMAL AND TRANSDERMAL ADMINISTRATION OF TREPROSTINIL AND SALTS THEREOF
#1120SKIN FIBROSIS TREATMENT AGENT
#1121Topical Compositions and Methods for Treatment of Diabetic Neuropathies
#1122Compositions and methods for reducing overdose
#1123Pharmaceutical composition and administrations thereof
#1124Liquid formulation of long-lasting protein conjugate comprising the oxyntomodulin and an immunoglobulin Fc region
#1125SOLID COMPOSITIONS OF ACTIVES, PROCESSES FOR PREPARING SAME AND USES OF SUCH SOLID COMPOSITIONS
#1126HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF
#1127TREATMENT OF PAIN WITH TOPICAL DICLOFENAC
#1128Viscosity-reducing excipient compounds for protein formulations
#1129Liquid pharmaceutical composition
#1130Antimicrobial compositions and methods employing same
#1131READY-TO-USE DEXMEDETOMIDINE COMPOSITIONS
#1132MODIFIER SYSTEM FOR COMPOSITIONS CONTAINING LAYERED DOUBLE HYDROXIDE
#1133Feminine hygiene products
#1134COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL
#1135Antibody formulations
#1136Method for administering omega-conopeptide
#1137Prostacyclin analogue formulations
#1138Topical composition and delivery system and its use
#1139SELF-EMULSIFYING LIPID COMPOSITIONS
#1140Liquid formulations of daptomycin
#1141Propylene Glycol-Containing Peptide Formulations which are Optimal for Production and for Use in Injection Devices
#1142SHP2 inhibitors and methods of use thereof
#1143METHODS OF TREATING OVARIAN CANCER
#1144Topical formulations comprising tofacitinib
#1145Compounded compositions and methods for treating pain
#1146Sulfonamide pharmaceutical composition
#1147Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
#1148COMPOSITIONS AND METHODS OF TREATING AND/OR PREVENTING LYSOSOMAL STORAGE DISEASES AND OTHER MONOGENETIC METABOLIC DISEASES
#1149Liquid pharmaceutical composition comprising an anti-IL-6 receptor antibody
#1150COLD-PROCESSED SELF-EMULSIFYING HYDROALCOHOLIC GEL COMPOSITIONS AND METHODS
#1151Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof
#1152Topical formulation and method for preventing or treating acne
#1153Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
#1154Soft chewable pharmaceutical products
#1155METHODS OF TREATING NEW-ONSET PLAQUE TYPE PSORIASIS USING IL-17 ANTAGONISTS
#1156BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#1157FORMULATIONS OF BENDAMUSTINE
#1158Composition and method for treating plantar fasciitis in humans
#1159Pheromone compositions for stimulating early onset of estrus and reducing labor needs in breeding peri-pubertal suids and methods of use
#1160COMPOSITION AND METHOD FOR TREATING HERPESVIRUS IN MAMMALS
#1161Methods and compositions for inactivating enveloped viruses
#1162Compositions and methods for treating an infection
#1163Topical compositions
#1164Lipids and compositions for the delivery of therapeutics
#1165Transdermal packaging membranes
#1166COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION OR INFECTION OF THE EYE
#1167Method of fabricating semiconductor device
#1168Botanical formulations
#1169Technology to inhibit vascular changes that lead to vision loss in the eye
#1170Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same
#1171Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
#1172Topical Compositions, Process of Manufacture and Method of Use
#1173Methods for the preparation of injectable depot compositions
#1174Sustained-release buprenorphine formulations
#1175Use of rice bran oil distillate extract for prevention and mitigation of the effects of radiation
#1176Method for manufacturing acetaminophen preparation
#1177Transdermal Cannabinoid Patch
#1178Nanoparticles carrying antibiotics
#1179Pharmaceutical composition for treating skin wounds and a method of treating skin wounds using thereof
#1180Formulations of a compound modulating kinases
#1181Oral formulations and lipophilic salts of methylnaltrexone
#1182Oral formulations and lipophilic salts of methylnaltrexone
#1183Pharmaceutical formulation containing gelling agent
#1184COMPOSITIONS AND METHODS FOR REDUCING INFECTION IN WOUNDS AND SURGICAL SITES
#1185Soft Chewable Pharmaceutical Product
#1186Soft Chewable Pharmaceutical Products
#1187Peptide with ability to penetrate cell membrane
#1188STABILISATION OF POLYPEPTIDES
#1189Microstructure formulation techniques for botulinum toxin
#1190Stabilised Solid Compositions of Factor VII Polypeptides
#1191Pharmaceutical Formulation Containing Gelling Agent
#1192O/W type emulsion
#1193ExPEC glycoconjugate vaccine formulations
#1194METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE, AND VASCULAR CONDITIONS
#1195Nanoparticle-induced fusogenicity between liposome and endosome membranes for targeted delivery through endosomal escape
#1196COMPOSITIONS, METHODS, COMBINATION TREATMENTS
#1197Polymyxin B-coated nanoparticles
#1198BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#1199Delayed release pharmaceutical composition of pantoprazole and process for formulation thereof
#1200ADHESIVE PATCH